cadmium has been researched along with brimonidine tartrate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fredholm, BB; Hu, PS | 1 |
Dooley, DJ; Hertting, G; Lupp, A; Osswald, H | 1 |
Boehm, S; Huck, S | 1 |
3 other study(ies) available for cadmium and brimonidine tartrate
Article | Year |
---|---|
Alpha 2-adrenoceptor agonist-mediated inhibition of [3H]noradrenaline release from rat hippocampus is reduced by 4-aminopyridine, but that caused by an adenosine analogue or omega-conotoxin is not.
Topics: 4-Aminopyridine; Adenosine; Adrenergic alpha-Agonists; Aminopyridines; Animals; Brimonidine Tartrate; Cadmium; Cadmium Chloride; Conotoxins; Hippocampus; Male; Mollusk Venoms; Norepinephrine; Phenylisopropyladenosine; Quinoxalines; Rats; Rats, Inbred Strains; Yohimbine | 1989 |
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.
Topics: Aminopyridines; Animals; Brimonidine Tartrate; Cadmium; Calcium Channel Blockers; Dioxanes; Hippocampus; Idazoxan; In Vitro Techniques; Mollusk Venoms; Neomycin; Nicotinic Acids; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Phorbol Esters; Quinoxalines; Rabbits | 1988 |
Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors.
Topics: Adrenergic alpha-Agonists; Animals; Bradykinin; Brimonidine Tartrate; Cadmium; Calcium; Cells, Cultured; In Vitro Techniques; Neurotransmitter Agents; Norepinephrine; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Adrenergic, alpha-2; Receptors, Bradykinin; Superior Cervical Ganglion; Tetrodotoxin; Thapsigargin | 1997 |